In the US, growing investments in biomedical research, biotechnology, proteomics, and molecular biology are increasing demand for specialized CSPG2 antibody solutions. The country’s strong pharmaceutical and biotechnology ecosystem, advanced research infrastructure, and expanding focus on biomarker discovery and disease mechanism studies are supporting the adoption of validated...